MedPath

Comparison intravenous Phosphorus to Oral Phosphate for Treatment of hypophosphatemia

Phase 3
Conditions
Disorders of phosphorus metabolism and phosphatases.
Disorders of phosphorus metabolism and phosphatases
Registration Number
IRCT20150107020592N18
Lead Sponsor
Masih Daneshvari Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
140
Inclusion Criteria

Patient over 18 years old
Admitted to Intensive Care Unit

Exclusion Criteria

The patient needs renal replacement therapy
The patient that has a serum potassium concentration greater than 5 m.mol / L.
Patient without basic phosphate level
Chronic kidney failure with and without dialysis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Phosphor level. Timepoint: Before & After intervention. Method of measurement: Before intervention and 3 days after intervention.
Secondary Outcome Measures
NameTimeMethod
Compensation of hypophosphatemia. Timepoint: Before & After intervention. Method of measurement: Before intervention and 3 days after intervention.;Duration of stay in ICU. Timepoint: From the time of admission to the exit from the ICU. Method of measurement: Number of hospital days in ICU.
© Copyright 2025. All Rights Reserved by MedPath